099190 — I Sens Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for I Sens, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	Annual Audited Accounts	ARS	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	232,935	264,837	265,120	291,138	315,445
Cost of Revenue
Gross Profit	102,064	105,486	106,059	113,534	125,261
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	198,034	244,845	257,936	296,115	314,894
Operating Profit	34,901	19,993	7,185	-4,977	551
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	30,741	19,153	6,133	1,652	-10,669
Provision for Income Taxes
Net Income After Taxes	25,151	15,908	3,404	-1,953	-6,691
Minority Interest
Net Income Before Extraordinary Items
Net Income	25,451	16,138	3,709	-1,794	-5,149
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	25,451	16,138	3,709	-1,794	-5,149
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,010	487	210	-214	-6.89
Dividends per Share